| Ryan Killian Duffy, MD | |
|
264 Pleasant St, Concord, NH 03301-2551 | |
| (603) 224-3368 | |
| (603) 224-7815 |
| Full Name | Ryan Killian Duffy |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 16 Years |
| Location | 264 Pleasant St, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225200215 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0801X | Orthopaedic Surgery - Orthopaedic Trauma | 18315 (New Hampshire) | Secondary |
| 207X00000X | Orthopaedic Surgery | 18315 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Concord Hospital | Concord, NH | Hospital |
| Lakes Region General Hospital | Laconia, NH | Hospital |
| Speare Memorial Hospital | Plymouth, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Concord Orthopaedics Professional Association | 3870562960 | 44 |
News Archive
Center for Companies That Care has announced that University HealthSystem Consortium was named to its Honor Roll, a national list recognizing employers for outstanding workplace practices and active community involvement, for the eighth consecutive year.
The Iranian mental health system should pay more attention to responding to non-medical expectations of service users. The measurement of responsiveness can inform us how well the mental health care system interacts with the population. These are the conclusion drawn in a dissertation by Ameneh Setareh Forouzan at Umeå University in Sweden.
Clear Guide Medical has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative CT-Ultrasound fusion and image guidance system, the Clear Guide SCENERGY.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
› Verified 2 days ago
| Entity Name | Speare Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346402047 PECOS PAC ID: 1153318068 Enrollment ID: O20040823001172 |
News Archive
Center for Companies That Care has announced that University HealthSystem Consortium was named to its Honor Roll, a national list recognizing employers for outstanding workplace practices and active community involvement, for the eighth consecutive year.
The Iranian mental health system should pay more attention to responding to non-medical expectations of service users. The measurement of responsiveness can inform us how well the mental health care system interacts with the population. These are the conclusion drawn in a dissertation by Ameneh Setareh Forouzan at Umeå University in Sweden.
Clear Guide Medical has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative CT-Ultrasound fusion and image guidance system, the Clear Guide SCENERGY.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
› Verified 2 days ago
| Entity Name | Concord Orthopaedics Professional Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437182490 PECOS PAC ID: 3870562960 Enrollment ID: O20040927000243 |
News Archive
Center for Companies That Care has announced that University HealthSystem Consortium was named to its Honor Roll, a national list recognizing employers for outstanding workplace practices and active community involvement, for the eighth consecutive year.
The Iranian mental health system should pay more attention to responding to non-medical expectations of service users. The measurement of responsiveness can inform us how well the mental health care system interacts with the population. These are the conclusion drawn in a dissertation by Ameneh Setareh Forouzan at Umeå University in Sweden.
Clear Guide Medical has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative CT-Ultrasound fusion and image guidance system, the Clear Guide SCENERGY.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
› Verified 2 days ago
| Entity Name | Speare Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528213428 PECOS PAC ID: 1153318068 Enrollment ID: O20090210000333 |
News Archive
Center for Companies That Care has announced that University HealthSystem Consortium was named to its Honor Roll, a national list recognizing employers for outstanding workplace practices and active community involvement, for the eighth consecutive year.
The Iranian mental health system should pay more attention to responding to non-medical expectations of service users. The measurement of responsiveness can inform us how well the mental health care system interacts with the population. These are the conclusion drawn in a dissertation by Ameneh Setareh Forouzan at Umeå University in Sweden.
Clear Guide Medical has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative CT-Ultrasound fusion and image guidance system, the Clear Guide SCENERGY.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
› Verified 2 days ago
| Entity Name | Cny Care Of Ny, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225590458 PECOS PAC ID: 0143656587 Enrollment ID: O20210412001810 |
News Archive
Center for Companies That Care has announced that University HealthSystem Consortium was named to its Honor Roll, a national list recognizing employers for outstanding workplace practices and active community involvement, for the eighth consecutive year.
The Iranian mental health system should pay more attention to responding to non-medical expectations of service users. The measurement of responsiveness can inform us how well the mental health care system interacts with the population. These are the conclusion drawn in a dissertation by Ameneh Setareh Forouzan at Umeå University in Sweden.
Clear Guide Medical has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative CT-Ultrasound fusion and image guidance system, the Clear Guide SCENERGY.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
› Verified 2 days ago
| Entity Name | Northeast Orthopaedic Alliance Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417724170 PECOS PAC ID: 5991149809 Enrollment ID: O20240223001001 |
News Archive
Center for Companies That Care has announced that University HealthSystem Consortium was named to its Honor Roll, a national list recognizing employers for outstanding workplace practices and active community involvement, for the eighth consecutive year.
The Iranian mental health system should pay more attention to responding to non-medical expectations of service users. The measurement of responsiveness can inform us how well the mental health care system interacts with the population. These are the conclusion drawn in a dissertation by Ameneh Setareh Forouzan at Umeå University in Sweden.
Clear Guide Medical has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative CT-Ultrasound fusion and image guidance system, the Clear Guide SCENERGY.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Killian Duffy, MD 264 Pleasant Street, Concord, NH 03301 Ph: (603) 224-3368 | Ryan Killian Duffy, MD 264 Pleasant St, Concord, NH 03301-2551 Ph: (603) 224-3368 |
News Archive
Center for Companies That Care has announced that University HealthSystem Consortium was named to its Honor Roll, a national list recognizing employers for outstanding workplace practices and active community involvement, for the eighth consecutive year.
The Iranian mental health system should pay more attention to responding to non-medical expectations of service users. The measurement of responsiveness can inform us how well the mental health care system interacts with the population. These are the conclusion drawn in a dissertation by Ameneh Setareh Forouzan at Umeå University in Sweden.
Clear Guide Medical has received 510(k) clearance from the U.S. Food and Drug Administration to market its innovative CT-Ultrasound fusion and image guidance system, the Clear Guide SCENERGY.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
› Verified 2 days ago
Clifford M Levy, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 264 Pleasant St, Concord, NH 03301 Phone: 603-224-3368 Fax: 603-224-7815 | |
Dr. Christopher Ernest Gentchos, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 264 Pleasant St, Concord, NH 03301 Phone: 603-224-3368 Fax: 603-724-2581 | |
Dr. Scott R Devanny, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St, Suite 106, Concord, NH 03301 Phone: 603-224-1223 Fax: 603-228-7133 | |
Jeffrey W Wiley, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 264 Pleasant St, Concord, NH 03301 Phone: 603-224-3368 Fax: 603-224-7815 | |
Dr. Neil T Dion, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 264 Pleasant St, Concord, NH 03301 Phone: 603-224-3368 Fax: 603-224-7815 | |
Anthony Vincent Mollano, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 264 Pleasant St, Concord, NH 03301 Phone: 603-224-3368 Fax: 603-224-7815 |